Generic Drugs Market in Japan 2015-2019

Published: Feb 2015 Pages: 94 SKU: IRTNTR5244

About Generic Drugs
A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded drugs. Generic drugs enter the market once the patent protection of the original developer expires. Generally, the cost of generic drugs is 50-70 percent lower than that of their brand-name counterparts, while meeting the very same standards of safety, quality, and efficacy as the innovator drugs. Generic drugs help the manufacturer by eliminating the need to develop and market a new drug. As the patent approaches expiration, manufacturers can apply to the FDA for approval to manufacture and sell generic versions of the drug. Generic drugs are equal to and within the bioequivalence range of branded drugs.

TechNavio's analysts forecast the Generic Drugs market in Japan to grow at a CAGR of 8.16 percent over the period 2014-2019.

Covered in this Report
The Generic Drugs market in Japan can be divided into three segments: Generic Prescription Medicines, Super Generics, and Biosimilars. This report covers the present scenario and the growth prospects of the Generic Drugs market in Japan for the period 2015–2019. To calculate the market size, the report considers the revenue generated from the following segments:

• Generic Prescription Medicines
• Super Generics
• Biosimilars

TechNavio's report, the Generic Drugs market in Japan 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the Generic Drugs market in Japan and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Vendors
• Meiji Seika Pharma
• Nichi-Iko Pharmaceutical
• Nipro Pharma
• Sawai Pharmaceuticals
• Teva Pharmaceutical Industries
• Towa Pharmaceutical

Other Prominent Vendors
• Actavis
• Daiichi Sankyo
• Daito Pharmaceutical
• Eisai
• Fuji Pharma
• GlaxoSmithKline
• Hikari Pharmaceutical
• Hospira
• Mylan
• Nihon Generic
• Nippon Chemipher
• Nippon Kayaku
• Nissin Pharmaceutical
• Ohara Pharmaceutical
• Pfizer
• Sandoz
• Taiyo Yakuhin
• Takeda Pharmaceutical
• Zensei Pharmaceutical Industries

Market Driver
• Increase in Number of Patent Expiries
• For a full, detailed list, view our report.

Market Challenge
• Intense Competition among Vendors
• For a full, detailed list, view our report

Market Trend
• Increase in M&A
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Country Overview of Japan
07. Approval Pathway of Generic Drugs in Japan
07.1 Master File Scheme for Active Ingredients
07.2 Equivalency Review
07.3 Conformity Audit
08. Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
 09. Market Segmentation by Product Category
10. Market Segmentation by Therapeutic Application
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1       Competitive Scenario
18.1.1    Key News
18.1.2    Mergers and Acquisitions
18.2       Market Share Analysis 2014
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Meiji Seika Pharma
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Business Segmentation
19.1.4 Business Strategy
19.1.5 Revenue by Business Segmentation
19.1.6 Revenue Comparison 2011 and 2012
19.1.7 Revenue by Geographical Segmentation
19.1.8 Key Information
19.1.9 SWOT Analysis
19.2 Nichi-Iko
19.2.1 Key Facts
19.2.2 Business Description
19.2.3 Business Segmentation
19.2.4 Business Strategy
19.2.5 Revenue by Business Segmentation
19.2.6 Revenue Comparison 2011 and 2012
19.2.7 Revenue by Geographical Segmentation
19.2.8 Key Information
19.2.9 SWOT Analysis
19.3 Nipro Pharma
19.3.1 Key Facts
19.3.2 Business Description
19.3.3 Business Segmentation
19.3.4 Business Strategy
19.3.5 Revenue by Business Segmentation
19.3.6 Revenue Comparison 2011 and 2012
19.3.7 Revenue by Geographical Segmentation
19.3.8 Key Information
19.3.9 SWOT Analysis
19.4 Sawai
19.4.1 Key Facts
19.4.2 Business Description
19.4.3 Business Segmentation
19.4.4 Business Strategy
19.4.5 Revenue by Business Segmentation
19.4.6 Revenue Comparison 2011 and 2012
19.4.7 Revenue by Geographical Segmentation
19.4.8 Key Information
19.4.9 SWOT Analysis
19.5 Teva Pharmaceutical Industries
19.5.1 Key Facts
19.5.2 Business Description
19.5.3 Business Segmentation
19.5.4 Business Strategy
19.5.5 Revenue by Business Segmentation
19.5.6 Revenue Comparison 2011 and 2012
19.5.7 Revenue by Geographical Segmentation
19.5.8 Key Information
19.5.9 SWOT Analysis
19.6 Towa Pharmaceutical
19.6.1 Key Facts
19.6.2 Business Description
19.6.3 Business Segmentation
19.6.4 Business Strategy
19.6.5 Revenue by Business Segmentation
19.6.6 Revenue Comparison 2011 and 2012
19.6.7 Revenue by Geographical Segmentation
19.6.8 Key Information
19.6.9 SWOT Analysis
20. Other Reports in this Series

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

PURCHASE FULL REPORT OF

market

QUICK BUY

Key Questions Answered

  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis